Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.
New research shows that a form of vitamin A used to treat acute promyelocytic leukemia induces changes in an unusual class of small molecules called microRNAs (miRNAs) in the leukemic cells.
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls.
A widely practiced, stress-reducing meditation technique significantly decreases the severity of congestive heart failure, according to a first-of-its-kind randomized study published in Ethnicity & Disease (Winter 2007).
Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) announced that ASAQ, the new fixed-dose combination of artesunate (AS) and amodiaquine (AQ), will soon be available throughout sub-Saharan Africa.
A study published in the March 1 issue of the journal Sleep finds that people with obstructive sleep apnea (OSA) are at an increased risk of having cardiovascular disease.
A study published in the March 1 issue of the journal Sleep finds that, as opposed to treating insomnia, failure to treat it is much more costly.
AVANIR Pharmaceuticals (NASDAQ:AVNR) announced the Company has met with U.S. Food and Drug Administration (FDA) officials to address concerns expressed in the FDA’s October 30, 2006 approvable letter for Zenvia(TM) as a treatment for involuntary emotional expression disorder (IEED) and to present AVANIR’s proposed strategy to gain approval for Zenvia for this indication.
Amgen (NASDAQ: AMGN) announced that the U.S. Food and Drug Administration (FDA) has invited the Company to participate at an upcoming meeting of the Oncologic Drugs Advisory Committee (ODAC).
The Indian Government has proposed to increase the allocation for the National Rural Health Mission (NRHM) from Rs.8,207 crore in 2006-07 to Rs.9,947 crore in 2007-08.